B&B Pharma SRL
The score of B&B Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +503 % Total assets -6 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
B&B Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 82,128 € | ||||
| Equity | 244,361 € | ||||
| Cash | 9,320 € | ||||
| EBITDA | 135,415 € | ||||
| Total assets | 811,436 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 05 Oct 2026
- Year ended 31 Dec 2024filed on 19 Aug 2025
- Year ended 31 Dec 2023filed on 29 Aug 2024
- Year ended 31 Dec 2022filed on 06 Aug 2023
- Year ended 31 Dec 2021filed on 13 Jul 2022
B&B Pharma's financial analysis
- Solvency30.1%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of B&B Pharma
B&B Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0554.988.666
- VAT number
- BE0554988666
- Peppol
- Registered · 0208:0554988666 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 02 Jul 2014
- Registered office
- 1650 Beersel
- Latest accounts
- 2025 · filed on 05 Oct 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
B&B Pharma (SRL) has been based in Beersel since 2014, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 82,128 € and equity of 244,361 €; its revenue is not published. Its solvency stands at 30.1%, below the median of its sector (44.0%).
Companies similar to B&B Pharma
Companies in the same business, of comparable size and area, outside its group.
- Trap Services Activities of holding companies Dilbeek · balance sheet 977,563 €
- Mara-SPL Activities of holding companies Beersel · balance sheet €1.20m
- Bloos Retail sale of pharmaceutical products Anzegem · balance sheet 824,528 €
- Donk DCL Farma Retail sale of pharmaceutical products Herk-de-Stad · balance sheet 897,538 €
- Apotheek DE Zuidflank Retail sale of pharmaceutical products Assenede · balance sheet 722,912 €
- Charlotte Theunissen Retail sale of pharmaceutical products Lanaken · balance sheet 962,662 €
- Mapant Retail sale of pharmaceutical products Retie · balance sheet €1.09m
- AP DE Haven Retail sale of pharmaceutical products Oostkamp · balance sheet €1.12m
Frequently asked questions about B&B Pharma
What is the revenue of B&B Pharma?
B&B Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of B&B Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0554988666 for B&B Pharma, if the company is VAT-registered. Its company number (CBE) is 0554.988.666.
Where is the registered office of B&B Pharma?
According to the CBE register, the registered office of B&B Pharma is in 1650 Beersel.
What is the equity of B&B Pharma?
At the close of the 2025 financial year, the equity of B&B Pharma amounts to 244,361 €, a solvency of 30.1% of total assets.
Who manages B&B Pharma?
The register lists 2 active mandates at B&B Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of B&B Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →